Zobrazeno 1 - 10
of 537
pro vyhledávání: '"N, Andratschke"'
Autor:
C.A. Fink, J. Ristau, C. Buchele, S. Klüter, J. Liermann, P. Hoegen-Saßmannshausen, E. Sandrini, A. Lentz-Hommertgen, L. Baumann, N. Andratschke, M. Baumgartl, M. Li, M. Reiner, S. Corradini, J. Hörner-Rieber, D. Bonekamp, H.-P. Schlemmer, C. Belka, M. Guckenberger, J. Debus, S.A. Koerber
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 46, Iss , Pp 100771- (2024)
Background: Due to superior image quality and daily adaptive planning, MR-guided stereotactic body radiation therapy (MRgSBRT) has the potential to further widen the therapeutic window in radiotherapy of localized prostate cancer. This study reports
Externí odkaz:
https://doaj.org/article/d7b743ca37de493b8a5a32eb4636b5e1
Autor:
J. Ristau, J. Hörner-Rieber, C. Buchele, S. Klüter, C. Jäkel, L. Baumann, N. Andratschke, H. Garcia Schüler, M. Guckenberger, M. Li, M. Niyazi, C. Belka, K. Herfarth, J. Debus, S. A. Koerber
Publikováno v:
Radiation Oncology, Vol 17, Iss 1, Pp 1-8 (2022)
Abstract Background Normofractionated radiation regimes for definitive prostate cancer treatment usually extend over 7–8 weeks. Recently, moderate hypofractionation with doses per fraction between 2.2 and 4 Gy has been shown to be safe and feasible
Externí odkaz:
https://doaj.org/article/0d9e915b0afa43ca9e6823c9ea6a51b9
Autor:
J. Schaule, M. Chamberlain, L. Wilke, M. Baumgartl, J. Krayenbühl, M. Zamburlini, M. Mayinger, N. Andratschke, S. Tanadini-Lang, M. Guckenberger
Publikováno v:
Radiation Oncology, Vol 16, Iss 1, Pp 1-7 (2021)
Abstract Background MR-guided online adaptive stereotactic body radiation therapy (SBRT) for prostate cancer aims to reduce toxicity by full compensation of interfractional uncertainties. However, the process of online adaptation currently takes appr
Externí odkaz:
https://doaj.org/article/2e0e3f67ac2b4679a2600a65744e45f5
Autor:
J-J Stelmes, E. Vu, V. Grégoire, C. Simon, E. Clementel, J. Kazmierska, W. Grant, M. Ozsahin, M. Tomsej, L. Vieillevigne, C. Fortpied, E. C. Hurkmans, A. Branquinho, N. Andratschke, F. Zimmermann, D.-C. Weber
Publikováno v:
Radiation Oncology, Vol 16, Iss 1, Pp 1-10 (2021)
Abstract Introduction The current phase III EORTC 1420 Best-of trial (NCT02984410) compares the swallowing function after transoral surgery versus intensity modulated radiotherapy (RT) in patients with early-stage carcinoma of the oropharynx, supragl
Externí odkaz:
https://doaj.org/article/86e0a4672aab4faea81dbdeb08666474
Autor:
I. Stiefel, C. Schröder, S. Tanadini-Lang, I. Pytko, E. Vu, R.J. Klement, M. Guckenberger, N. Andratschke
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 27, Iss , Pp 132-138 (2021)
Introduction: The use of cranial re-irradiation is growing with improving overall survival and the advent of high-precision radiotherapy techniques. Still the value of re-irradiation needs careful evaluation regarding safety and efficacy. We analyzed
Externí odkaz:
https://doaj.org/article/e01e819c6e934692ad0df1c0bf46d7aa
Autor:
M. Pavic, M. Bogowicz, J. Kraft, D. Vuong, M. Mayinger, S. G. C. Kroeze, M. Friess, T. Frauenfelder, N. Andratschke, M. Huellner, W. Weder, M. Guckenberger, S. Tanadini-Lang, I. Opitz
Publikováno v:
EJNMMI Research, Vol 10, Iss 1, Pp 1-8 (2020)
Abstract Background Careful selection of malignant pleural mesothelioma (MPM) patients for curative treatment is of highest importance, as the multimodal treatment regimen is challenging for patients and harbors a high risk of substantial toxicity. R
Externí odkaz:
https://doaj.org/article/157be0993d9347cf812f7f3e79657d8f
Autor:
S. Corradini, F. Alongi, N. Andratschke, C. Belka, L. Boldrini, F. Cellini, J. Debus, M. Guckenberger, J. Hörner-Rieber, F. J. Lagerwaard, R. Mazzola, M. A. Palacios, M. E. P. Philippens, C. P. J. Raaijmakers, C. H. J. Terhaard, V. Valentini, M. Niyazi
Publikováno v:
Radiation Oncology, Vol 14, Iss 1, Pp 1-12 (2019)
Abstract Magnetic Resonance-guided radiotherapy (MRgRT) marks the beginning of a new era. MR is a versatile and suitable imaging modality for radiotherapy, as it enables direct visualization of the tumor and the surrounding organs at risk. Moreover,
Externí odkaz:
https://doaj.org/article/1bfb0d05346f45899270035497950096
Autor:
Rainer J. Klement, N. Abbasi-Senger, S. Adebahr, H. Alheid, M. Allgaeuer, G. Becker, O. Blanck, J. Boda-Heggemann, T. Brunner, M. Duma, M. J. Eble, I. Ernst, S. Gerum, D. Habermehl, P. Hass, C. Henkenberens, G. Hildebrandt, D. Imhoff, H. Kahl, N. D. Klass, R. Krempien, V. Lewitzki, F. Lohaus, C. Ostheimer, A. Papachristofilou, C. Petersen, J. Rieber, T. Schneider, E. Schrade, R. Semrau, S. Wachter, A. Wittig, M. Guckenberger, N. Andratschke
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-12 (2019)
Abstract Background The aim of this analysis was to model the effect of local control (LC) on overall survival (OS) in patients treated with stereotactic body radiotherapy (SBRT) for liver or lung metastases from colorectal cancer. Methods The analys
Externí odkaz:
https://doaj.org/article/45109ae3975c46d881a47e2b3fa65683
Autor:
N. Andratschke, H. Alheid, M. Allgäuer, G. Becker, O. Blanck, J. Boda-Heggemann, T. Brunner, M. Duma, S. Gerum, M. Guckenberger, G. Hildebrandt, R. J. Klement, V. Lewitzki, C. Ostheimer, A. Papachristofilou, C. Petersen, T. Schneider, R. Semrau, S. Wachter, D. Habermehl
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-11 (2018)
Abstract Background The intent of this pooled analysis as part of the German society for radiation oncology (DEGRO) stereotactic body radiotherapy (SBRT) initiative was to analyze the patterns of care of SBRT for liver oligometastases and to derive f
Externí odkaz:
https://doaj.org/article/72c3c52d3f1e4f629c3fe45d746c7e25
Publikováno v:
Radiation Oncology, Vol 13, Iss 1, Pp 1-8 (2018)
Abstract Background Tumor immune-evasion and associated failure of immunotherapy can potentially be overcome by radiotherapy, which however also has detrimental effects on tumor-infiltrating and circulating lymphocytes (CL). We therefore established
Externí odkaz:
https://doaj.org/article/f2b4126fef8d4dad93b3b18cbea45d7b